[BLFS] BioLife Solutions, Inc.


Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 1.64 Change: 0.02 (1.23%)
Ext. hours: Change: 0 (0%)

chart BLFS

Refresh chart

Strongest Trends Summary For BLFS

BLFS is in the medium-term down -19% below S&P in 7 months. In the long-term up 704% in 5 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The company?s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. Its HypoThermosol series of products include HypoThermosol FRS, a solution formulated to decrease the free radical accumulation in cells undergoing prolonged hypothermic preservation; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. The company?s CryoStor series of products consist of CryoStor CS2, CryoStor CS5, and CryoStor CS10, which are cryopreservation freeze media products designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing. Its BloodStor products comprise BloodStor 5

Fundamental Ratios
Shares Outstanding EPS-0.51 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 23.84% Sales Growth - Q/Q-10.12% P/E-4.47
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-24.33% ROE-34.04% ROI
Current Ratio7.49 Quick Ratio6.64 Long Term Debt/Equity Debt Ratio0.14
Gross Margin53.57% Operating Margin-69.82% Net Profit Margin-65.57% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities20 K Cash From Investing Activities1.72 M Cash From Operating Activities-1.31 M Gross Profit880 K
Net Profit-1.03 M Operating Profit-1.16 M Total Assets15.16 M Total Current Assets10.96 M
Total Current Liabilities1.46 M Total Debt Total Liabilities4.32 M Total Revenue1.5 M
Technical Data
High 52 week21.26 Low 52 week9.5 Last close16.17 Last change-0.12%
RSI36.44 Average true range1.01 Beta0.28 Volume54.9 K
Simple moving average 20 days-5.7% Simple moving average 50 days-12.9% Simple moving average 200 days-6.41%
Performance Data
Performance Week4.19% Performance Month-21.54% Performance Quart-2.82% Performance Half-5.49%
Performance Year25.45% Performance Year-to-date34.41% Volatility daily3.71% Volatility weekly8.31%
Volatility monthly17.02% Volatility yearly58.96% Relative Volume505.82% Average Volume187.69 K
New High New Low


2020-05-18 16:15:00 | BioLife Solutions Promotes Marcus Schulz to Vice President, Global Sales

2020-05-14 20:30:57 | Biolife Solutions Inc BLFS Q1 2020 Earnings Call Transcript

2020-05-14 16:05:00 | BioLife Solutions Announces First Quarter 2020 Financial Results

2020-05-13 12:52:04 | CytoDyn CYDY to Report Q4 Earnings: What's in the Cards?

2020-05-13 10:20:02 | Why Earnings Season Could Be Great for BioLife Solutions BLFS

2020-05-11 08:00:00 | BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020

2020-05-01 08:00:00 | BioLife Solutions Announces Preliminary First Quarter 2020 Revenue

2020-04-20 06:44:21 | Is BioLife Solutions, Inc. NASDAQ:BLFS A Volatile Stock?

2020-03-30 18:35:04 | Edited Transcript of BLFS earnings conference call or presentation 11-Mar-20 8:30pm GMT

2020-03-28 08:45:21 | How Does BioLife Solutions's NASDAQ:BLFS P/E Compare To Its Industry, After The Share Price Drop?

2020-03-14 08:58:46 | Did You Miss BioLife Solutions's NASDAQ:BLFS Whopping 428% Share Price Gain?

2020-03-14 08:38:45 | How Does BioLife Solutions's NASDAQ:BLFS P/E Compare To Its Industry, After The Share Price Drop?

2020-03-11 16:29:00 | BioLife Solutions Announces Fourth Quarter and Full Year 2019 Financial Results

2020-03-11 14:30:00 | BioLife Solutions, Inc. to Host Earnings Call

2020-02-17 06:14:39 | What Does BioLife Solutions, Inc.'s NASDAQ:BLFS Share Price Indicate?

2020-02-12 08:00:00 | BioLife Solutions Announces Earnings Call Date and Upcoming Investor and Scientific Conferences

2020-02-07 07:46:02 | Analysts Back a Turnaround at BioLife Solutions

2020-01-22 05:46:37 | Here's Why We Think BioLife Solutions NASDAQ:BLFS Is Well Worth Watching

2019-12-30 11:35:43 | How Much Did BioLife Solutions, Inc.'s NASDAQ:BLFS CEO Pocket Last Year?

2019-12-26 20:13:18 | What could you have made by investing $1,000 in these Washington companies a decade ago?

2019-12-19 21:26:02 | Smart Money Dumping BioLife Solutions, Inc. BLFS

2019-12-04 06:58:46 | Can BioLife Solutions, Inc. NASDAQ:BLFS Maintain Its Strong Returns?

2019-12-02 08:00:00 | BioLife Solutions Announces Executive Appointments to Support Integration of Acquired Companies

2019-11-22 03:01:00 | Seattle has potential as a biotech hub, but more companies must stay here and grow

2019-11-21 07:49:34 | Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT

2019-11-12 16:03:00 | BioLife Solutions Acquires Custom Biogenic Systems

2019-11-12 16:01:00 | BioLife Solutions Announces Third Quarter 2019 Financial Results

2019-11-11 08:07:29 | Is BioLife Solutions, Inc. NASDAQ:BLFS Creating Value For Shareholders?

2019-11-07 18:15:55 | BioLife Solutions, Inc. BLFS: Hedge Fund Interest Cooling Off

2019-11-07 08:00:00 | BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte's 2019 Technology Fast 500™

2019-10-31 20:23:00 | BioLife Solutions to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019

2019-10-22 09:13:01 | Medical Products Industry Outlook: Prospects Seem Promising

2019-10-14 09:41:00 | A Quick Look at 2 Positive Looking Biotech Plays

2019-10-14 08:00:00 | BioLife Solutions Awarded Three New Patents for Cryopreservation, Thawing and Cold Chain Transport Technologies

2019-09-24 08:00:00 | BioLife Solutions Announces Cell and Gene Therapy Bioproduction Innovation Accelerator

2019-09-24 08:00:00 | iVexSol Announces $2M in Seed Funding

2019-09-16 08:00:00 | BioLife Solutions Announces New evo® Cold Chain Customers

2019-09-11 22:15:02 | Biolife Solutions Inc BLFS President & CEO Michael Rice Sold $553,992 of Shares

2019-09-06 22:15:02 | Biolife Solutions Inc BLFS CFO Greef Roderick De Sold $593,400 of Shares

2019-09-03 08:00:00 | Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution

2019-08-28 08:00:00 | BioLife Solutions Strengthens Sales Team with Key Leadership Additions

2019-08-12 08:00:00 | BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences

2019-08-10 21:12:13 | Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT

2019-08-08 23:23:47 | Biolife Solutions Inc BLFS Q2 2019 Earnings Call Transcript

2019-08-08 16:05:00 | BioLife Solutions Announces Second Quarter 2019 Financial Results

2019-08-08 08:05:00 | BioLife Solutions Completes Acquisition of SAVSU Technologies

2019-08-02 22:15:03 | Biolife Solutions Inc BLFS CFO Greef Roderick De Sold $568,800 of Shares

2019-08-01 10:33:02 | BioLife Solutions BLFS Expected to Beat Earnings Estimates: Can the Stock Move Higher?

2019-07-31 08:00:00 | BioLife Solutions to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019

2019-07-30 08:00:00 | SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies